TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries

Thursday, Nov. 29, 2012, 12:40 p.m.
 

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.

 

 

 


Show commenting policy

Most-Read Stories

  1. Penguins notebook: Road trip increases in difficulty
  2. Agent: Polamalu undecided whether to play in 2015
  3. Federal jury says gas company shorted owners on royalties
  4. Mt. Lebanon deer-culling corrals sprayed with urine, repellent
  5. Loose barges on the Mon highlight woes of winter’s end
  6. Police looking for man they say assaulted a 13-year-old girl
  7. Starkey: In defense of Mel Kiper Jr.
  8. Penguins forwards struggle in loss to Avalanche
  9. Parkway East closure lifted after truck with loose load of coils forces detour
  10. Audit: Pitt oversight of youth camp staff backgrounds spotty
  11. Seneca Valley special-needs student left on bus